ReviewFrontiers in immunology2023

Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer.

Flávia Sardela de Miranda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.